---
$id: https://graph.org.ai/products/commodity/51171957
$type: Product
source: UNSPSC
code: "51171957"
title: "Proglumide"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proglumide

**UNSPSC Code**: 51171957
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C18H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EPL8W5565D, chemically known as 2,5-diamino-5-oxopentanoic acid but generally known as proglumide, which bears US NIH Compound Identifier 738. European Medicines Agency schedules Proglumide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10078MIG. The term PROGLUMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules proglumide in its Anatomical Therapeutic Chemical (ATC) Classification. PROGLUMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proglumide under HS 29242995 and SITC 51479. As of Q4 2014, PROGLUMIDE remains the US FDA Preferred Term for this commodity. Proglumide bears US NLM identifiers UMLS ID C0033321 and NCI Concept Code C81916. SMILES: OC(=O)C(N)CCC(=O)N.

